today announced positive initial data from the first patient dosed in its ongoing Phase 1/2 clinical study of PM359 in Chronic Granulomatous Disease (CGD). Preliminary results from the first ...

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common but poorly understood condition. Previously known as 'non-bacterial' prostatitis, CP/CPPS is the most common clinical ...

Indeed, a T-cell immune response to PSA in patients with chronic prostatitis has been reported 80. In summary, many non-infectious mechanisms might lead to prostate epithelial cell and stromal damage.

Researchers designed the treatment to correct a mutation that causes chronic granulomatous disease, a dangerous condition that disables a variety of immune cells, including those called neutrophils.

In this case, the patient does not have features fully consistent with a diagnosis of Crohn's disease. The presentation is more in keeping with a diagnosis of ileitis of spondylarthropathy. It can ...

It is like a vicious cycle. A: Chronic prostatitis can have a huge impact on quality of life. Symptoms vary and it can be challenging to treat. You haven’t mentioned which symptoms your father ...

CAMBRIDGE, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic ...

Despite hitting a clinical “milestone,” Prime Medicine is shelving its sole clinical-stage genetic medicine. The Cambridge, Massachusetts-based biotech is also laying off staffers and CEO ...

As part of the move, the company is scrapping its lead program in one subtype of chronic granulomatous disease, or CGD, a rare immune deficiency that leaves patients vulnerable to life-threatening ...

variant of autosomal recessive chronic granulomatous disease (CGD), accounting for 25% of patients with CGD, according to the NIH’s National Library of Medicine. Prime estimates that CGD ...